人乳头瘤病毒疫苗接种：过去、现在与未来
Human Papillomavirus Vaccination: Past, Present and Future.
作者信息
Aimagambetova Gulzhanat, Azizan Azliyati
机构信息
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
Basic Sciences Department, College of Osteopathic Medicine, Touro University Nevada, Henderson, NV 89014, USA.
出版信息
Vaccines (Basel). 2022 Aug 26;10(9):1398. doi: 10.3390/vaccines10091398.
Abstract
The link between human papillomavirus (HPV) infection and different diseases has been well-established since more than four decades ago [...].
摘要
自四十多年前以来，人乳头瘤病毒（HPV）感染与不同疾病之间的联系就已得到充分证实[……]
相似文献
1
Human Papillomavirus Vaccination: Past, Present and Future.
Vaccines (Basel). 2022 Aug 26;10(9):1398. doi: 10.3390/vaccines10091398.
2
Human papillomavirus (HPV): making the case for 'Immunisation for All'.
Oral Dis. 2017 Sep;23(6):726-730. doi: 10.1111/odi.12562. Epub 2016 Aug 29.
3
[Status of Human Papillomavirus Vaccination and Knowledge,Attitudes, and Influencing Factors towards Human Papillomavirus and Its Vaccines among University Students in Western China].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021 Aug;43(4):545-550. doi: 10.3881/j.issn.1000-503X.13153.
4
Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
Reprod Health. 2022 Jun 10;19(1):136. doi: 10.1186/s12978-022-01444-4.
5
[Human papillomavirus infection and vaccination].
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jan 6;52(1):106-112. doi: 10.3760/cma.j.issn.0253-9624.2018.01.021.
6
Human Papillomavirus Vaccines: Successes and Future Challenges.
Drugs. 2018 Sep;78(14):1385-1396. doi: 10.1007/s40265-018-0975-6.
7
Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
JAMA Oncol. 2017 Jun 1;3(6):810-816. doi: 10.1001/jamaoncol.2016.6192.
8
Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
Vaccine. 2018 Jul 5;36(29):4311-4316. doi: 10.1016/j.vaccine.2018.05.104. Epub 2018 Jun 5.
9
Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: community-based cross-sectional study.
Sex Transm Infect. 2021 Sep;97(6):458-460. doi: 10.1136/sextrans-2020-054428. Epub 2020 Sep 3.
10
Association of human papillomavirus vaccination with exposure to dental or medical visits.
J Public Health Dent. 2020 Sep;80(4):327-332. doi: 10.1111/jphd.12408. Epub 2020 Oct 10.
引用本文的文献
1
Cervicovaginal Microbiome: Physiology, Age-Related Changes, and Protective Role Against Human Papillomavirus Infection.
J Clin Med. 2025 Feb 24;14(5):1521. doi: 10.3390/jcm14051521.
2
Prevalence of high-risk human papillomavirus infection and genotype distribution among Kazakhstani women with abnormal cervical cytology.
Ann Med. 2024 Dec;56(1):2304649. doi: 10.1080/07853890.2024.2304649. Epub 2024 Jan 18.
3
Primary prevention of HPV-related diseases from the patients' perspective in Poland.
Eur J Cancer Prev. 2024 Jul 1;33(4):299-308. doi: 10.1097/CEJ.0000000000000866. Epub 2023 Nov 30.
4
Reproductive and Obstetric Outcomes after Fertility-Sparing Treatments for Cervical Cancer: Current Approach and Future Directions.
J Clin Med. 2023 Mar 30;12(7):2614. doi: 10.3390/jcm12072614.
5
Prevalence of Precancerous Cervical Lesions among Nonvaccinated Kazakhstani Women: The National Tertiary Care Hospital Screening Data (2018).
Healthcare (Basel). 2023 Jan 12;11(2):235. doi: 10.3390/healthcare11020235.
本文引用的文献
1
What Factors Are Associated with Attitudes towards HPV Vaccination among Kazakhstani Women? Exploratory Analysis of Cross-Sectional Survey Data.
Vaccines (Basel). 2022 May 23;10(5):824. doi: 10.3390/vaccines10050824.
2
Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
PLoS One. 2021 Dec 13;16(12):e0261203. doi: 10.1371/journal.pone.0261203. eCollection 2021.
3
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
Lancet. 2021 Dec 4;398(10316):2084-2092. doi: 10.1016/S0140-6736(21)02178-4. Epub 2021 Nov 3.
4
Human Papillomavirus Vaccination After COVID-19.
JNCI Cancer Spectr. 2021 Mar 2;5(2):pkab011. doi: 10.1093/jncics/pkab011. eCollection 2021 Apr.
5
National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects.
Prev Med. 2021 Mar;144:106335. doi: 10.1016/j.ypmed.2020.106335. Epub 2021 Mar 4.
6
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.
Prev Med. 2021 Mar;144:106399. doi: 10.1016/j.ypmed.2020.106399. Epub 2020 Dec 31.
7
Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
Int J Gynaecol Obstet. 2021 Jan;152(1):32-39. doi: 10.1002/ijgo.13482.
8
How to recover lost vaccine acceptance? A multi-center survey on HPV vaccine acceptance in Japan.
J Infect Chemother. 2021 Mar;27(3):445-449. doi: 10.1016/j.jiac.2020.10.012. Epub 2020 Oct 27.
9
Factors associated with adolescent HPV vaccination in the U.S.: A systematic review of reviews and multilevel framework to inform intervention development.
Prev Med. 2020 Feb;131:105968. doi: 10.1016/j.ypmed.2019.105968. Epub 2019 Dec 24.
10
Human papillomavirus vaccination: Ongoing challenges and future directions.
Gynecol Oncol. 2020 Feb;156(2):498-502. doi: 10.1016/j.ygyno.2019.10.018. Epub 2019 Dec 14.
Zotero 插件